Purple Biotech (PPBT) Enterprise Value (2014 - 2026)
Purple Biotech's (PPBT) quarterly Enterprise Value came in at -$6.5 million in Q1 2026, up 1.31% year-on-year from -$6.4 million in Q1 2025, and up 32.66% on a QoQ basis from -$9.6 million in Q4 2025.
Purple Biotech (PPBT) Enterprise Value (2014 - 2026) Analysis & Trends
Purple Biotech (PPBT) has 13 years of Enterprise Value data on file, last reported at -$6.5 million in Q1 2026.
- On a quarterly basis, Enterprise Value rose 1.31% year-over-year to -$6.5 million in Q1 2026; TTM through Mar 2026 was -$6.5 million, a 1.31% increase from a year earlier, with the FY2025 full-year figure at -$9.6 million, down 798.23% from the prior year.
- Enterprise Value for Q1 2026 stood at -$6.5 million, up from -$9.6 million in the prior quarter.
- Over the last five years, Enterprise Value for PPBT reached as high as -$1.1 million in Q4 2024 and fell as low as -$39.3 million in Q1 2022.
- Historically, Enterprise Value has averaged -$15.2 million across 5 years, with a median of -$10.8 million in 2024.
- Across the five-year window, Enterprise Value jumped 92.97% in 2024 and plunged 798.23% in 2025, its largest moves.
- Year by year, Enterprise Value stood at -$15.3 million in 2022, then increased by 0.16% to -$15.2 million in 2023, then soared by 92.97% to -$1.1 million in 2024, then sank by 798.23% to -$9.6 million in 2025, then surged by 32.66% to -$6.5 million in 2026.
- Per Business Quant data, the three most recent Enterprise Value figures were -$6.5 million in Q1 2026, -$9.6 million in Q4 2025, and -$10.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -283.54 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | -61.40 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | -4.79 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -32.26 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | -7.25 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -8.75 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | -5.18 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -1.91 Bn |
| 10 | Purple Biotech | 1.33 Bn | 1.33 Bn | - | -6.48 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -6.48 Mn |
| Dec 31, 2025 | -9.63 Mn |
| Sep 30, 2025 | -10.41 Mn |
| Jun 30, 2025 | -5.55 Mn |
| Mar 31, 2025 | -6.57 Mn |
| Dec 31, 2024 | -1.07 Mn |
| Sep 30, 2024 | -6.23 Mn |
| Jun 30, 2024 | -7.31 Mn |
| Mar 31, 2024 | -10.76 Mn |
| Dec 31, 2023 | -15.25 Mn |
| Sep 30, 2023 | -15.83 Mn |
| Jun 30, 2023 | -17.91 Mn |
| Mar 31, 2023 | -22.57 Mn |
| Dec 31, 2022 | -15.27 Mn |
| Sep 30, 2022 | -32.87 Mn |
| Jun 30, 2022 | -35.77 Mn |
| Mar 31, 2022 | -39.29 Mn |
| Dec 31, 2021 | -46.92 Mn |
| Sep 30, 2021 | -45.25 Mn |
| Jun 30, 2021 | -48.06 Mn |